Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer
Purpose. Concurrent chemoradiotherapy (CCRT) has been widely applied to locally advanced cervical cancer (LACC) patients, inducing the massive release of antigen and systematic immunomodulatory effects. However, its effect on the soluble immune checkpoint proteins (sICPs) remains unclear, which migh...
Saved in:
| Main Authors: | Chao Liu, Xiaohui Li, Aijie Li, Wenxue Zou, Rui Huang, Xiaoyu Hu, Jinming Yu, Xiaoling Zhang, Jinbo Yue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/9621466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed
by: Swaroop Revannasiddaiah, et al.
Published: (2013-01-01) -
Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer: a multicenter real-world study
by: Jiwei Li, et al.
Published: (2025-05-01) -
Hematological parameters during concurrent chemoradiotherapy as potential prognosticators in patients with stage IIB cervical cancer
by: Oyeon Cho, et al.
Published: (2017-02-01) -
Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma
by: Oyeon Cho, et al.
Published: (2017-10-01) -
Locally Advanced Cervical Cancer in a Patient with Epidermolysis Bullosa Treated with Concurrent Chemoradiotherapy and Electronic Brachytherapy
by: Desislava Hitova-Topkarova, et al.
Published: (2025-01-01)